Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
August 6, 2021

Medical Devices industry internet of things deals total $820.9m globally in Q2 2021

The Carlyle Group’s $435m private equity deal with Unchained Labs was the medical devices industry’s biggest internet of things deal of Q2 2021 as internet of things deals worth $820.9m were announced globally in the quarter, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 751.7% over the previous quarter and a rise of 111.2% when compared with the last four-quarter average of $388.64m.

In terms of number of internet of things deals, the sector saw a rise of 14.29% with 22 deals in Q2 2021 against the average of 19.25 deals in the last four-quarters.

In value terms, North America led the activity with internet of things deals worth $524.29m.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

medical devices industry internet of things deals in Q2 2021: Top deals

The top five medical devices industry internet of things deals accounted for 89.4% of the overall value during Q2 2021.

The combined value of the top five internet of things deals stood at $734m, against the overall value of $820.9m recorded for the quarter.

The top five medical devices industry internet of things deals of Q2 2021 tracked by GlobalData were:

1) The Carlyle Group’s $435m private equity deals with Unchained Labs

2) The $130m venture financing with Huma Therapeutics by HAT SGR, Hitachi Ventures, Leaps by Bayer, Samsung NEXT Fund, Sony Innovation Fund and Unilever Ventures

3) Credit Suisse Entrepreneur Capital, Endeavour Vision, Federated Hermes Kaufmann Fund, GMS Capital, Kingdon Capital Management, SchroderBank AG, Tandem Diabetes Care, VI Partners and Ypsomed’s $115m venture financing of CeQur

4) The $34m venture financing of Zus Health by Andreessen Horowitz, F-Prime, Martin Ventures, Maverick Ventures, Oxeon Investments and Rock Health

5) Atinum Investment, KB Investment, Korea Investment Partners, LB Investment, MORU Asset Management and Soo Investment Capital’s venture financing with Sky Labs for $20m.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU